Skip to main content

Kura Oncology, Inc.

KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001422143

In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Kura Oncology, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
165
+24 vs. Q4 2023
Shares held
80.8M
+2.00M (+2.5%) vs. Q4 2023
Total value
$1.72B
+$589.5M (+52.1%) vs. Q4 2023
New holders
40
55 more added
Sold out
16
47 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 165 institutions
Q1 2021: 171 institutionsQ2 2021: 171 institutionsQ3 2021: 152 institutionsQ4 2021: 151 institutionsQ1 2022: 152 institutionsQ2 2022: 148 institutionsQ3 2022: 148 institutionsQ4 2022: 142 institutionsQ1 2023: 141 institutionsQ2 2023: 148 institutionsQ3 2023: 133 institutionsQ4 2023: 141 institutionsQ1 2024: 165 institutionsQ2 2024: 174 institutionsQ3 2024: 179 institutionsQ4 2024: 185 institutionsQ1 2025: 183 institutionsQ2 2025: 182 institutionsQ3 2025: 200 institutionsQ4 2025: 215 institutionsQ1 2026: 222 institutionsQ2 2026: 221 institutions
Value heldQ1 2024: $1.72B
Q1 2021: $1.94BQ2 2021: $1.41BQ3 2021: $1.25BQ4 2021: $897.8MQ1 2022: $1.06BQ2 2022: $1.26BQ3 2022: $977.5MQ4 2022: $870.3MQ1 2023: $885.3MQ2 2023: $795.1MQ3 2023: $686.9MQ4 2023: $1.13BQ1 2024: $1.72BQ2 2024: $1.66BQ3 2024: $1.61BQ4 2024: $686.3MQ1 2025: $530.9MQ2 2025: $473.6MQ3 2025: $742.6MQ4 2025: $888.2MQ1 2026: $686.5MQ2 2026: $953.1M
Institutions holding KURA and their total value by quarter
QuarterHoldersValue
Q2 2026221$953.1M
Q1 2026222$686.5M
Q4 2025215$888.2M
Q3 2025200$742.6M
Q2 2025182$473.6M
Q1 2025183$530.9M
Q4 2024185$686.3M
Q3 2024179$1.61B
Q2 2024174$1.66B
Q1 2024165$1.72B
Q4 2023141$1.13B
Q3 2023133$686.9M
Q2 2023148$795.1M
Q1 2023141$885.3M
Q4 2022142$870.3M
Q3 2022148$977.5M
Q2 2022148$1.26B
Q1 2022152$1.06B
Q4 2021151$897.8M
Q3 2021152$1.25B
Q2 2021171$1.41B
Q1 2021171$1.94B

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Kura Oncology, Inc.; share changes are against Q4 2023.

Institutions holding KURA in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Two Sigma Advisers, LP86,500$1.85M0.00%+64,900+300.5%Added
UBS Asset Management Americas Inc86,666$1.85M0.00%+4,810+5.9%Added
Acuta Capital Partners, LLC90,000$1.92M1.25%−611,349−87.2%Reduced
DekaBank Deutsche Girozentrale95,000$1.99M0.00%00.0%Unchanged
Squarepoint Ops LLC95,288$2.03M0.01%+129+0.1%Added
Tang Capital Management LLC100,000$2.13M0.22%+100,000New
Swiss National Bank102,400$2.18M0.00%00.0%Unchanged
Barclays PLC103,912$2.22M0.00%−103,360−49.9%Reduced
American Century Companies Inc109,155$2.33M0.00%+41,889+62.3%Added
Cubist Systematic Strategies, LLC109,161$2.33M0.03%+83,950+333.0%Added
Moody Aldrich Partners LLC109,851$2.34M0.40%+109,851New
Rhumbline Advisers113,608$2.42M0.00%+1,545+1.4%Added
Propel Bio Management, LLC130,000$2.77M1.61%00.0%Unchanged
Jane Street Group, LLC162,073$3.46M0.00%+63,758+64.9%Added
Rhenman & Partners Asset Management AB166,526$3.55M0.34%+166,526New
Two Sigma Investments, LP177,650$3.79M0.01%+177,650New
Hennion & Walsh Asset Management, Inc.181,674$3.88M0.21%+54,031+42.3%Added
Nuveen Asset Management, LLC210,166$4.48M0.00%+10,753+5.4%Added
Russell Investments Group, Ltd.224,296$4.78M0.01%−488−0.2%Reduced
UBS Group AG226,821$4.84M0.00%+23,864+11.8%Added
Renaissance Technologies LLC240,200$5.12M0.01%−37,900−13.6%Reduced
Bank of New York Mellon Corp244,685$5.22M0.00%−16,104−6.2%Reduced
Alethea Capital Management, LLC259,606$5.54M4.50%−90,839−25.9%Reduced
Citigroup Inc271,896$5.80M0.01%+203,663+298.5%Added
Algert Global LLC279,570$5.96M0.23%−53,880−16.2%Reduced
Logos Global Management LP300,000$6.40M0.67%+300,000New
Rafferty Asset Management, LLC311,268$6.64M0.02%+159,994+105.8%Added
Invesco Ltd.314,072$6.70M0.00%+244,945+354.3%Added
Verition Fund Management LLC361,820$7.72M0.07%−103,773−22.3%Reduced
Ally Bridge Group (NY) LLC365,044$7.79M4.33%+365,044New
D. E. Shaw & Co., Inc.389,902$8.32M0.01%+184,282+89.6%Added
DAFNA Capital Management LLC412,663$8.80M2.00%−80,021−16.2%Reduced
JPMorgan Chase & Co434,396$9.27M0.00%−38,596−8.2%Reduced
Bank of America Corp480,622$10.3M0.00%−270,719−36.0%Reduced
Millennium Management LLC488,216$10.4M0.01%+355,726+268.5%Added
Sofinnova Investments, Inc.501,940$10.7M0.63%−1,165,381−69.9%Reduced
Susquehanna International Group, LLP594,879$12.7M0.02%+530,196+819.7%Added
Charles Schwab Investment Management Inc598,724$12.8M0.00%+18,737+3.2%Added
Sphera Funds Management Ltd.610,826$13.0M2.11%−92,461−13.1%Reduced
Candriam Luxembourg S.C.A.651,417$13.9M0.09%+110,000+20.3%Added
Northern Trust Corp694,346$14.8M0.00%−15,474−2.2%Reduced
Affinity Asset Advisors, LLC730,492$15.6M2.53%+538,957+281.4%Added
Goldman Sachs Group Inc785,876$16.8M0.00%+254,314+47.8%Added
Prosight Management, LP960,000$20.5M5.70%+10,000+1.1%Added
Boxer Capital, LLC1,000,000$21.3M1.05%+1,000,000New
Assenagon Asset Management S.A.1,153,845$24.6M0.07%00.0%Unchanged
Morgan Stanley1,357,461$29.0M0.00%+26,506+2.0%Added
Dimensional Fund Advisors LP1,363,435$29.1M0.01%−638,319−31.9%Reduced
TCG Crossover Management, LLC1,423,642$30.4M2.40%00.0%Unchanged
Commodore Capital LP1,525,000$32.5M2.18%+276,938+22.2%Added
Franklin Resources Inc1,575,246$33.6M0.01%+221,581+16.4%Added
Geode Capital Management, LLC1,707,274$36.4M0.00%+51,265+3.1%Added
Foresite Capital Management IV, LLC1,849,947$39.5M19.94%00.0%Unchanged
Artal Group S.A.1,919,884$41.0M1.06%+151,828+8.6%Added
Armistice Capital, LLC2,048,000$43.7M1.16%−176,000−7.9%Reduced
Holocene Advisors, LP2,437,463$52.0M0.19%00.0%Unchanged
Paradigm Biocapital Advisors LP3,135,387$66.9M2.35%+1,872,559+148.3%Added
Avoro Capital Advisors LLC3,850,000$82.1M0.96%+870,000+29.2%Added
Vanguard Group Inc4,065,903$86.7M0.00%+28,212+0.7%Added
State Street Corp4,199,954$89.6M0.00%+1,278,144+43.7%Added
BVF Inc4,786,293$102.1M2.81%−2,586,935−35.1%Reduced
Deerfield Management Company, L.P. (Series C)5,411,571$115.4M2.01%+98,838+1.9%Added
EcoR1 Capital, LLC5,806,871$123.9M3.15%00.0%Unchanged
BlackRock Inc.6,899,369$147.2M0.00%−416,278−5.7%Reduced
Suvretta Capital Management, LLC7,069,627$150.8M6.36%+123,397+1.8%Added
Kennedy Capital Management, Inc.0$00.00%−113,715−100.0%Sold out
HRT Financial LP0$00.00%−94,279−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−75,000−100.0%Sold out
Ensign Peak Advisors, Inc0$00.00%−71,742−100.0%Sold out
Jupiter Asset Management Ltd0$00.00%−57,877−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−39,349−100.0%Sold out
Pale Fire Capital SE0$00.00%−31,050−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−25,527−100.0%Sold out
Advisory Research Inc0$00.00%−24,804−100.0%Sold out
Martingale Asset Management L P0$00.00%−21,222−100.0%Sold out
Point72 Middle East FZE0$00.00%−20,366−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−18,917−100.0%Sold out
Cape Investment Advisory, Inc.0$00.00%−12,219−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−11,891−100.0%Sold out
nVerses Capital, LLC0$00.00%–Sold out
Quest Partners LLC0$00.00%−343−100.0%Sold out